Literature DB >> 10586955

Induction of vascular endothelial growth factor after application of mechanical stress to retinal pigment epithelium of the rat in vitro.

Y Seko1, Y Seko1, H Fujikura, J Pang, T Tokoro, H Shimokawa.   

Abstract

PURPOSE: To investigate the response to mechanical stress of vascular endothelial growth factor (VEGF) production by cultured retinal pigment epithelial (RPE) cells.
METHODS: A pulsatile stretch device was used in vitro. RPE cells of the second passage were seeded onto flexible-bottomed culture plates; then, at subconfluent culture, the plates were subjected to pulsatile stretch. Culture plates prepared in the same way but not subjected to stretch were used as controls. After stretching for 1 hour or 24 hours, conditioned medium for measurement of VEGF production by RPE cells was collected using a mouse VEGF immunoassay. To study the expression of VEGF in RPE cells, passaged-cultured RPE cells were exposed to pulsatile stretch for 0, 1, 3, or 14 hours. Total cytoplasmic RNA was then prepared from the RPE cells. Northern blot analysis was performed for VEGF, with G3PDH used as an internal control.
RESULTS: The expression and secretion of VEGF in RPE cells were increased by pulsatile stretching.
CONCLUSIONS: Results indicate that stretching of the RPE could result in increased production of VEGF, with associated risk for neovascularization and changes in the blood-retinal barrier.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10586955

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  32 in total

1.  High incidence of vitreomacular traction in recurrent choroidal neovascularisation after repeated photodynamic therapy.

Authors:  J C Schmidt; S Mennel; S Hörle; C H Meyer
Journal:  Br J Ophthalmol       Date:  2006-07-19       Impact factor: 4.638

Review 2.  Roles for VEGF in the adult.

Authors:  Arindel S R Maharaj; Patricia A D'Amore
Journal:  Microvasc Res       Date:  2007-04-06       Impact factor: 3.514

3.  Clinical features of simple hemorrhage and myopic choroidal neovascularization associated with lacquer cracks in pathologic myopia.

Authors:  Peifang Ren; Li Lu; Xuyuan Tang; Hong Lu; Yuan Zhao; Dinghua Lou; Wei Han
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2020-07-09       Impact factor: 3.117

4.  [Spectral domain optical coherence tomography in the treatment of myopic choroidal neovascularization].

Authors:  M D Fischer; W Inhoffen; F Ziemssen
Journal:  Ophthalmologe       Date:  2012-08       Impact factor: 1.059

5.  Role of shear-stress-induced VEGF expression in endothelial cell survival.

Authors:  Nathaniel G dela Paz; Tony E Walshe; Lyndsay L Leach; Magali Saint-Geniez; Patricia A D'Amore
Journal:  J Cell Sci       Date:  2012-03-07       Impact factor: 5.285

6.  The effects of epiretinal membranes on the treatment outcomes of intravitreal aflibercept injection in diabetic macular edema: a real-life study.

Authors:  Ayse Gul Kocak Altintas; Cagri Ilhan; Mahmut Cankurtaran
Journal:  Int Ophthalmol       Date:  2020-05-29       Impact factor: 2.031

7.  A morphometric study of mechanotransductively induced dermal neovascularization.

Authors:  Paolo Erba; Lino F Miele; Avner Adini; Maximilian Ackermann; James M Lamarche; Britlyn D Orgill; Robert J D'Amato; Moritz A Konerding; Steven J Mentzer; Dennis P Orgill
Journal:  Plast Reconstr Surg       Date:  2011-10       Impact factor: 4.730

Review 8.  Dietary hyperglycemia, glycemic index and metabolic retinal diseases.

Authors:  Chung-Jung Chiu; Allen Taylor
Journal:  Prog Retin Eye Res       Date:  2010-09-22       Impact factor: 21.198

Review 9.  Management of Myopic Choroidal Neovascularization: Focus on Anti-VEGF Therapy.

Authors:  Kelvin Yi Chong Teo; Wei Yan Ng; Shu Yen Lee; Chui Ming Gemmy Cheung
Journal:  Drugs       Date:  2016-07       Impact factor: 9.546

10.  Microarray analysis of retinal gene expression in Egr-1 knockout mice.

Authors:  Ruth Schippert; Frank Schaeffel; Marita Pauline Feldkaemper
Journal:  Mol Vis       Date:  2009-12-10       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.